Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Sales (2024 - 2025)

Compass Therapeutics' Return on Sales history spans 2 years, with the latest figure at 68.85% for Q1 2025.

  • For Q1 2025, Return on Sales changed N/A year-over-year to 68.85%; the TTM value through Mar 2025 reached 68.85%, changed N/A, while the annual FY2024 figure was 66.62%, N/A changed from the prior year.
  • Return on Sales for Q1 2025 was 68.85% at Compass Therapeutics, down from 61.97% in the prior quarter.
  • Across five years, Return on Sales topped out at 15.38% in Q2 2024 and bottomed at 68.85% in Q1 2025.